Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Diabetes

Free Subscription Articles published in Am J Ophthalmol Retrieve available abstracts of 62 articles: HTML format

Single Articles

March 2026
1. WU AL, Hao J, Gao L, Guo Y, et al
   Elevated Retinal Neovascularization on Widefield Optical Coherence Tomography Angiography Predicts Complications in High-Risk Proliferative Diabetic Retinopathy.
   Am J Ophthalmol. 2026;283:268-278.
   PubMed     Abstract available
   
   
   February 2026
2. KHANGURA MS, Spratt MA, Gao A, Manhapra A, et al
   The Association Between Diabetic Retinopathy Severity and Dementia Risk: A TriNetX Longitudinal Cohort Study.
   Am J Ophthalmol. 2026 Feb 13:S0002-9394(26)00073.
   PubMed     Abstract available
   
   
   
3. MURRAY M, Schifano F, Chiappini S, Corkery JM, et al
   Reply to comment on: "Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists: an examination of the FAERS database" (Am J Ophthalmol. 2025 Dec 20;S0002-9394(25)00666-X).
   Am J Ophthalmol. 2026 Feb 10:S0002-9394(26)00062.
   PubMed    
   
   
   
4. SANCHEZ VMA
   Comment on: Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS database.
   Am J Ophthalmol. 2026 Feb 9:S0002-9394(26)00061.
   PubMed    
   
   
   
5. ZHOU J, Lee DA, Talebi Y, Wu G, et al
   Risk of Dementia in Type 2 Diabetes Patients with Open-Angle Glaucoma: Insights from a Nationwide Real-World Cohort Study.
   Am J Ophthalmol. 2026 Feb 7:S0002-9394(26)00060.
   PubMed     Abstract available
   
   
   January 2026
6. VIGGIANO P, Carra A, Bruno G, Boscia G, et al
   Microaneurysm Reflectivity as a prognostic biomarker for intravitreal Treatment Response in Diabetic Retinopathy.
   Am J Ophthalmol. 2026 Jan 28:S0002-9394(26)00043.
   PubMed     Abstract available
   
   
   
7. HE L, Guo X, Yong Z, Zha Y, et al
   Reply to Comment on: Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-PRP.
   Am J Ophthalmol. 2026 Jan 20:S0002-9394(26)00022.
   PubMed    
   
   
   
8. KAKIHARA S, Fawzi AA
   Comment on: Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-Pan-Retinal Photocoagulation.
   Am J Ophthalmol. 2026 Jan 14:S0002-9394(26)00021.
   PubMed    
   
   
   December 2025
9. MURRAY M, Schifano F, Chiappini S, Corkery JM, et al
   Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database.
   Am J Ophthalmol. 2025 Dec 20:S0002-9394(25)00666.
   PubMed     Abstract available
   
   
   
10. HONG AT, Lin F, Baxter S, Weinreb RN, et al
    Tirzepatide is Associated with Reduced Risk of Primary Open-Angle Glaucoma and Ocular Hypertension in Patients with Type 2 Diabetes.
    Am J Ophthalmol. 2025 Dec 6:S0002-9394(25)00653.
    PubMed     Abstract available
    
    
    November 2025
11. ANOZIE CC JR, Cox VF, Wiseman MT Jr, Lewis JE, et al
    Racial and ethnic disparities in risk for adverse ocular events in patients with diabetic retinopathy.
    Am J Ophthalmol. 2025 Nov 12:S0002-9394(25)00593.
    PubMed     Abstract available
    
    
    
12. HE L, Guo X, Yong Z, Zha Y, et al
    Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-PRP.
    Am J Ophthalmol. 2025 Nov 9:S0002-9394(25)00587.
    PubMed     Abstract available
    
    
    October 2025
13. AHUJA AS, Paredes AA 3rd, Ahuja SA, Young BK, et al
    Glucagon-like Peptide-1 Receptor Agonist Use and Risk of Cataract Development.
    Am J Ophthalmol. 2025 Oct 21:S0002-9394(25)00558.
    PubMed     Abstract available
    
    
    
14. WANG TW, Luo WT, Tu YK, Chou YB, et al
    Diagnostic Accuracy of EyeArt for Fundus-Based Detection of Diabetic Retinopathy: A Systematic Review and Meta-analysis.
    Am J Ophthalmol. 2025 Oct 4:S0002-9394(25)00528.
    PubMed     Abstract available
    
    
    September 2025
15. FAN Y, Li L, Wu X, Yan Y, et al
    Longitudinal neural and microvascular changes in type 2 diabetic patients without retinopathy: a 2-year prospective cohort study.
    Am J Ophthalmol. 2025 Sep 19:S0002-9394(25)00503.
    PubMed     Abstract available
    
    
    
16. PAN SY, Weng CH, Tsai SF, Sheen YJ, et al
    Comparative Risk of Glaucoma in Patients Using Sodium-glucose Cotransporter-2 Inhibitors and Metformin: A Multinational Cohort Study.
    Am J Ophthalmol. 2025 Sep 19:S0002-9394(25)00504.
    PubMed     Abstract available
    
    
    August 2025
17. HUSSAIN ZS, Chauhan MZ, Muayad J, Loya A, et al
    Potency Matters: The Role of Statin Intensity in Modulating Risk for Age-Related Macular Degeneration.
    Am J Ophthalmol. 2025 Aug 17:S0002-9394(25)00430.
    PubMed     Abstract available
    
    
    July 2025
18. PRASAD M, Agron E, Vitale S, Arunachalam T, et al
    Diabetic retinopathy incidence, progression, and health-related quality of life from the ACCORD trial.
    Am J Ophthalmol. 2025 Jul 23:S0002-9394(25)00371.
    PubMed     Abstract available
    
    
    June 2025
19. NWANYANWU K, Andoh J, Chen E, Xu Y, et al
    Social Determinants Associated with Diabetic Retinopathy Awareness: National Health and Nutrition Examination Survey (2005-2008).
    Am J Ophthalmol. 2025 Jun 21:S0002-9394(25)00330.
    PubMed     Abstract available
    
    
    May 2025
20. PARK KS, Kim JT, Lee MW
    Macular Microvasculature Asymmetry Analysis for Evaluating Open-Angle Glaucoma in Diabetic Retinopathy Patients Treated with Pan-Retinal Photocoagulation.
    Am J Ophthalmol. 2025 May 23:S0002-9394(25)00248.
    PubMed     Abstract available
    
    
    
21. LAKHANI M, Kwan AT, Mihalache A, Popovic MM, et al
    Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries.
    Am J Ophthalmol. 2025 May 16:S0002-9394(25)00239.
    PubMed     Abstract available
    
    
    
22. HUSSAIN ZS, Shakarchi AF, Chauhan MZ, Jester DA, et al
    Is There a Safe Glycemic Threshold for Cataract Surgery?
    Am J Ophthalmol. 2025 May 3:S0002-9394(25)00221.
    PubMed     Abstract available
    
    
    March 2025
23. LIANG F, Tao S, Zhang Y, Liu S, et al
    Correlation between length of interdigitation zone with severity and progression of diabetic retinopathy.
    Am J Ophthalmol. 2025 Mar 27:S0002-9394(25)00152.
    PubMed     Abstract available
    
    
    
24. WANG Z, Yu Y, Ye Y, Wang L, et al
    Associations between Ambient Air Pollution and Five Common Vision-threatening Ocular Diseases in Middle-aged and Older Adults: A Large Prospective Cohort Study.
    Am J Ophthalmol. 2025 Mar 6:S0002-9394(25)00121.
    PubMed     Abstract available
    
    
    February 2025
25. LI M, He J, VanderBeek BL, Ying GS, et al
    Racial and Ethnic Disparities at Enrollment in DRCRnet Clinical Trials for Diabetic Macular Edema.
    Am J Ophthalmol. 2025 Feb 26:S0002-9394(25)00095.
    PubMed     Abstract available
    
    
    
26. JANMOHAMED IK, Salam MAU, Jamall O, Elgharably M, et al
    Faricimab-Associated Intraocular Inflammation with Features of Herpes Simplex Virus.
    Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00096.
    PubMed     Abstract available
    
    
    
27. ABBASS NJ, Nahlawi R, Shaia JK, Allan KC, et al
    The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy.
    Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00094.
    PubMed     Abstract available
    
    
    
28. KHAN Z, Gaidhane AM, Singh M, Ganesan S, et al
    Diagnostic Accuracy of IDX-DR for Detecting Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Am J Ophthalmol. 2025 Feb 20:S0002-9394(25)00081.
    PubMed     Abstract available
    
    
    
29. MAGRATH G, Luvisi J, Russakoff D, Oakley J, et al
    Use of a Convolutional Neural Network to Predict the Response of Diabetic Macular Edema to Intravitreal Anti-VEGF Treatment: A Pilot Study.
    Am J Ophthalmol. 2025 Feb 20:S0002-9394(25)00073.
    PubMed     Abstract available
    
    
    
30. ANGUITA R, Desideri LF, Sivaprasad S, Wickham L, et al
    Reply to "Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy".
    Am J Ophthalmol. 2025 Feb 6:S0002-9394(25)00050.
    PubMed    
    
    
    
31. UZUN S, Blair MP
    Comment on: Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2025 Feb 5:S0002-9394(25)00049.
    PubMed    
    
    
    January 2025
32. TAKKAR B, Ketkar MR, Narula R, Tyagi M, et al
    A pilot randomized controlled trial evaluating haemostasis with fibrin glue during surgery for proliferative diabetic retinopathy.
    Am J Ophthalmol. 2025 Jan 28:S0002-9394(25)00040.
    PubMed     Abstract available
    
    
    December 2024
33. HUANG RS, Balas M, Jhaveri A, Popovic MM, et al
    Comparison of Renal Adverse Events Between Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Meta-Analysis.
    Am J Ophthalmol. 2024 Dec 31:S0002-9394(24)00590.
    PubMed     Abstract available
    
    
    
34. AMARAL DC, Guedes J, Cruz MRB, Cheidde L, et al
    GLP-1 RECEPTOR AGONISTS USE AND INCIDENCE OF GLAUCOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS: GLP-1 receptor agonists use and incidence of glaucoma.
    Am J Ophthalmol. 2024 Dec 26:S0002-9394(24)00589.
    PubMed     Abstract available
    
    
    
35. ANGUITA R, Desideri LF, Sivaprasad S, Wickam L, et al
    Reply to Comment on "Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy".
    Am J Ophthalmol. 2024 Dec 18:S0002-9394(24)00573.
    PubMed    
    
    
    
36. NISHIDA K, Maeno T, Nishida K
    Comment on, Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Dec 17:S0002-9394(24)00572.
    PubMed    
    
    
    November 2024
37. MOU K, Zhang M
    Comment on "Retinal and Choroidal Phenotypes Across Novel Subtypes of Type 2 Diabetes Mellitus".
    Am J Ophthalmol. 2024 Nov 28:S0002-9394(24)00546.
    PubMed    
    
    
    
38. LIU K, Li T, Zhong P, Zhu Z, et al
    Reply to Comment on "Retinal and Choroidal Phenotypes Across Novel Subtypes of Type 2 Diabetes Mellitus".
    Am J Ophthalmol. 2024 Nov 28:S0002-9394(24)00547.
    PubMed    
    
    
    
39. ZAMAN M, Zajner C, Xie J, Patil NS, et al
    Association Between Sociodemographic Factors and Self-Reported Diabetic Retinopathy: A Cross-sectional, Population-Based Analysis.
    Am J Ophthalmol. 2024 Nov 16:S0002-9394(24)00524.
    PubMed     Abstract available
    
    
    
40. ENG K, Zebardast N, Boland MV, Lo JE, et al
    Sodium-glucose cotransporter 2 inhibitors and glaucoma in patients with type 2 diabetes.
    Am J Ophthalmol. 2024 Nov 6:S0002-9394(24)00506.
    PubMed     Abstract available
    
    
    October 2024
41. ANGUITA R, Ferro Desideri L, Schwember P, Shah N, et al
    Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Oct 27:S0002-9394(24)00488.
    PubMed     Abstract available
    
    
    
42. DING X, Romano F, Garg I, Gan J, et al
    Expanded Field OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in Non-Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Oct 25:S0002-9394(24)00485.
    PubMed     Abstract available
    
    
    September 2024
43. KIM A, Ding X, Miller JB
    Ultra-widefield Swept-Source OCT Angiography vs. Ultra-widefield Fluorescein Angiography in Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Sep 17:S0002-9394(24)00419.
    PubMed    
    
    
    
44. TSAI WS, Thottarath S, Gurudas S, Pearce E, et al
    A Comparison of Optical Coherence Tomography Angiography Metrics and Artifacts on Scans of Different Sizes in Diabetic Macular Ischemia: The effect of different size scans on DMI evaluation.
    Am J Ophthalmol. 2024 Sep 13:S0002-9394(24)00433.
    PubMed     Abstract available
    
    
    
45. LUM F
    Comment on Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Study.
    Am J Ophthalmol. 2024 Sep 6:S0002-9394(24)00406.
    PubMed    
    
    
    
46. WAI KM, Mishra K, Koo E, Ludwig CA, et al
    Reply to comment on: Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.
    Am J Ophthalmol. 2024 Sep 4:S0002-9394(24)00407.
    PubMed    
    
    
    
47. LIU K, Li T, Zhong P, Zhu Z, et al
    Longitudinal changes in retina and choroid across novel subtypes of diabetes mellitus: Subtypes of diabetes and retinal neurovascular changes.
    Am J Ophthalmol. 2024 Sep 3:S0002-9394(24)00405.
    PubMed     Abstract available
    
    
    
48. HALLAJ S, Halfpenny W, Chuter BG, Weinreb RN, et al
    Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change.
    Am J Ophthalmol. 2024 Sep 3:S0002-9394(24)00392.
    PubMed     Abstract available
    
    
    August 2024
49. LEE MY, Han K, Min KH, Yu DS, et al
    Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study.
    Am J Ophthalmol. 2024 Aug 30:S0002-9394(24)00395.
    PubMed     Abstract available
    
    
    
50. LEE SH, Tseng BY, Wu MC, Wang JH, et al
    Incidence and Progression of Diabetic Retinopathy After Cataract Surgery: A Systematic Review and Meta-Analysis.
    Am J Ophthalmol. 2024 Aug 21:S0002-9394(24)00379.
    PubMed     Abstract available
    
    
    July 2024
51. RAHMATI M, Smith L, Boyer L, Fond G, et al
    Factors affecting global adherence for the uptake of diabetic retinopathy screening: A systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Jul 31:S0002-9394(24)00335.
    PubMed     Abstract available
    
    
    
52. RAHIMY E, Koo EB, Wai KM, Ludwig CA, et al
    Impact of Obstructive Sleep Apnea on Diabetic Retinopathy Progression and Systemic Complications.
    Am J Ophthalmol. 2024 Jul 30:S0002-9394(24)00323.
    PubMed     Abstract available
    
    
    
53. BANTOUNOU MA, Nahar TAK, Plascevic J, Kumar N, et al
    Drug exposure as a predictor in diabetic retinopathy risk prediction models; a systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Jul 19:S0002-9394(24)00313.
    PubMed     Abstract available
    
    
    June 2024
54. ARRUDA MP, Lima RV, Hira S, Moreira JLML, et al
    A Comprehensive Meta-Analysis on the Role of Analgesics and Anti-Inflammatories in Pan-retinal Photocoagulation.
    Am J Ophthalmol. 2024 Jun 26:S0002-9394(24)00264.
    PubMed     Abstract available
    
    
    May 2024
55. LI G, Sommi A, Klawe J, Ahmad S, et al
    Demographic and Systemic Risk Factors for Persistent Corneal Edema Following Cataract Surgery in Patients With and Without Diabetes.
    Am J Ophthalmol. 2024 May 25:S0002-9394(24)00228.
    PubMed     Abstract available
    
    
    
56. LIU X, Chang Y, Li Y, Liu Y, et al
    Association Between Cardiovascular Health and Retinopathy in US Adults: From NHANES 2005-2008.
    Am J Ophthalmol. 2024 May 16:S0002-9394(24)00223.
    PubMed     Abstract available
    
    
    
57. YILMAZ YC, Hayat SC, Ipek SC
    Corrigendum to Yilmaz YC, Hayat SC, Ipek SC. 'Analysis of Corneal and Lens Densitometry Changes in Patients With Type 1 Diabetes Mellitus' Am J Ophthalmol. 2023 Oct;254:23-30.
    Am J Ophthalmol. 2024 May 10:S0002-9394(24)00147.
    PubMed    
    
    
    
58. VOICHANSKI S, Bousquet E, Abraham N, Santina A, et al
    En Face Optical Coherence Tomography Illustrates the Trizonal Distribution of Drusen and Subretinal Drusenoid Deposits in the Macula.
    Am J Ophthalmol. 2024;261:187-198.
    PubMed     Abstract available
    
    
    April 2024
59. WAI KM, Mishra K, Koo E, Ludwig CA, et al
    Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.
    Am J Ophthalmol. 2024 Apr 16:S0002-9394(24)00150.
    PubMed     Abstract available
    
    
    March 2024
60. JOSEPH S, Selvaraj J, Mani I, Kumaragurupari T, et al
    Diagnostic accuracy of artificial intelligence based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Mar 2:S0002-9394(24)00066.
    PubMed     Abstract available
    
    
    February 2024
61. DAI Y, Zheng D, Zhao J, Wang K, et al
    Macular Neural and Microvascular Alterations in Type 2 Diabetes Without Retinopathy: A SS-OCT Study.
    Am J Ophthalmol. 2024 Feb 28:S0002-9394(24)00090.
    PubMed     Abstract available
    
    
    November 2023
62. DANZINGER V, Schartmuller D, Lisy M, Schranz M, et al
    Intraindividual Comparison Of An Enhanced Monofocal And An Aspheric Monofocal Intraocular Lens Of The Same Platform.
    Am J Ophthalmol. 2023 Nov 7:S0002-9394(23)00463.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum